EUVIMEDEUVIMED entdecken
Crossref

Epimedium brevicornu flavonoids alleviate neuroinflammation and Alzheimer’s disease pathology via immune-related pathways

Siyi Li, Dinghang Xiao, Reyisha Yusufu, Fenfen Huang, Yanping Feng, Alimasi Abudureyimu, Jiahao Zhao, Hanpeng Jiang, Fenghuan Wei

Phytomedicine · 2026-07 · 157 · 158299

DOI: 10.1016/j.phymed.2026.158299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Siyi Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Epimedium, Flavonoids, Neuroprotective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: With global population aging, Alzheimer's disease (AD) has become a critical clinical challenge. This multifactorial neurodegenerative disorder is characterized by amyloid-β aggregation, tau hyperphosphorylation, and neuroinflammation. The lack of effective disease-modifying therapies highlights the urgent need for multi-target strategies. Epimedium brevicornu flavonoids (EF), derived from a traditional medicinal plant used to support cognitive function, exhibit significant neuroprotective potential; however, the underlying mechanisms remain to be fully elucidated. PURPOSE: To investigate the neuroprotective effects and underlying mechanisms of EF against lipopolysaccharide (LPS)-induced neuroinflammation and Alzheimer's disease-related pathology. METHODS: EF were extracted and quantitatively analyzed. Mice were pretreated with EF for 14 days before LPS injection (1.0 mg/kg). Behavioral performance was assessed using the Open field, Y-maze, and Morris water maze tests. EF components in extract, serum, and brain were characterized by UHPLC-QTOF-MS/MS. Network pharmacology and molecular docking were employed to predict active compounds, targets, and signaling pathways. ELISA, Western blot, and immunofluorescence were conducted to evaluate cytokine levels, microglial and astrocytic activation, Aβ42 deposition, tau phosphorylation, and NeuN+ neuronal density. The involvement of PI3K/AKT and cGAS-STING pathways was further validated. In BV2 microglia, NO release and iNOS/Iba1 as well as CD206/Iba1 expression were examined to verify anti-inflammatory effects of EF in vitro. RESULTS: A total of 127 components in EF were identified, among which 45 and 38 were detected in serum and brain, respectively. The key compounds showed favorable target binding (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseEpimediumFlavonoidsNeuroprotective AgentsNeuroinflammatory DiseasesAnimalsMiceMaleSignal TransductionLipopolysaccharidesMice, Inbred C57BLMolecular Docking SimulationMicrogliaPlant ExtractsBrain

Stichwörter der Autor:innen

Alzheimer’s disease-like pathologyEpimedium brevicornu flavonoidsNeuroprotectionPI3K/AKT signaling pathwaycGAS-STING signaling pathway

Substanzen

FlavonoidsNeuroprotective AgentsLipopolysaccharidesPlant Extracts

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
  • Shanghai AB Sciex Analytical Instrument Trading Co. Ltd, Shanghai, 200335, China.
  • School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China. Electronic address: awag7674@smu.edu.cn.

Förderung

  • Guangzhou Municipal Science and Technology Project
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Li, S., Xiao, D., Yusufu, R., Huang, F., Feng, Y., Abudureyimu, A., Zhao, J., Jiang, H., & Wei, F. (2026). Epimedium brevicornu flavonoids alleviate neuroinflammation and Alzheimer’s disease pathology via immune-related pathways. Phytomedicine, 157, 158299. https://doi.org/10.1016/j.phymed.2026.158299

Vancouver

Li S, Xiao D, Yusufu R, Huang F, Feng Y, Abudureyimu A, et al. Epimedium brevicornu flavonoids alleviate neuroinflammation and Alzheimer’s disease pathology via immune-related pathways. Phytomedicine. 2026;157:158299. doi:10.1016/j.phymed.2026.158299

BibTeX
@article{Li2026,
  author = {Li, Siyi and Xiao, Dinghang and Yusufu, Reyisha and Huang, Fenfen and Feng, Yanping and Abudureyimu, Alimasi and Zhao, Jiahao and Jiang, Hanpeng and Wei, Fenghuan},
  title = {Epimedium brevicornu flavonoids alleviate neuroinflammation and Alzheimer’s disease pathology via immune-related pathways},
  journal = {Phytomedicine},
  year = {2026},
  volume = {157},
  pages = {158299},
  doi = {10.1016/j.phymed.2026.158299}
}
Kostenlos starten →